ロード中...
IL-23 and PSMA-targeted duo-CAR T cells in Prostate Cancer Eradication in a preclinical model
BACKGROUND: Prostate cancer is one of the most common adult malignancies in men, and nearly all patients with metastatic prostate cancer can develop and receive resistance to primary androgen deprivation therapy (ADT), a state known as metastatic castration-resistant prostate cancer (mCRPC). Recent...
保存先:
| 出版年: | J Transl Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6961333/ https://ncbi.nlm.nih.gov/pubmed/31937346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-02206-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|